Literature DB >> 12880979

Fenretinide as an anti-angiogenic agent in neuroblastoma.

Domenico Ribatti1, Lizzia Raffaghello, Danilo Marimpietri, Emilio Cosimo, P Giuseppe Montaldo, Beatrice Nico, Angelo Vacca, Mirco Ponzoni.   

Abstract

Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12880979     DOI： 10.1016/s0304-3835(03)00105-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


  5 in total

1.  Dysregulated ceramides metabolism by fatty acid 2-hydroxylase exposes a metabolic vulnerability to target cancer metastasis.

Authors:  Xuantong Zhou; Furong Huang; Gang Ma; Wenqing Wei; Nan Wu; Zhihua Liu
Journal:  Signal Transduct Target Ther       Date:  2022-10-24

2.  Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma.

Authors:  Sanjeev A Vasudevan; Xiaoying Shang; Xiaoyi Shang; Shirong Chang; Ningling Ge; Jose L Diaz-Miron; Heidi V Russell; M John Hicks; Andrew D Ludwig; Catherine L Wesson; Susan M Burlingame; Eugene S Kim; Javed Khan; Jianhua Yang; Jed G Nuchtern
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

3.  Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.

Authors:  Louis Chesler; David D Goldenberg; Isha T Seales; Ronit Satchi-Fainaro; Matt Grimmer; Rodney Collins; Chris Struett; Kim N Nguyen; Grace Kim; Tarik Tihan; Yun Bao; Rolf A Brekken; Gabriele Bergers; Judah Folkman; William A Weiss
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

4.  Implication of ceramide, ceramide 1-phosphate and sphingosine 1-phosphate in tumorigenesis.

Authors:  Patricia Gangoiti; Maria H Granado; Alicia Alonso; Félix M Goñi; Antonio Gómez-Muñoz
Journal:  Transl Oncogenomics       Date:  2008-04-10

Review 5.  Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.

Authors:  Isabella Orienti; Giovanna Angela Gentilomi; Giovanna Farruggia
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.